Journal of Cell Science 116, e804-e804 (2003)
Copyright © 2003 The Company of Biologists Limited
A novel endocytic pathway
The endothelial adhesion molecules ICAM-1 and PECAM-1 internalize various
particles, including natural ligands, apoptotic fragments and antibody
conjugates used for drug delivery. The endocytic vesicles involved are
100-300-nm in diameter, which is compatible with both major endocytic
mechanisms: the caveolar pathway and the clathrin-dependent pathway.
Nevertheless the mode of ICAM-1/PECAM-1 internalization is not known. Michael
Koval and co-workers have therefore analysed uptake of fluorescent
anti-PECAM-1 and anti-ICAM-1 conjugates by human umbilical vein endothelial
cells (see p. 1599). They find
that neither conjugate colocalizes with clathrin or caveolin when internalized
and that inhibitors of caveolae- or clathrin-mediated endocytosis fail to
block their internalization. Moreover, the authors show that actin `cups' do
not form around the internalized particles, eliminating the possibility that
phagocytosis is responsible. Interestingly, however, they do find that
ICAM-1-mediated endocytosis can be inhibited by a dominant negative mutant of
dynamin 2 (a GTPase that helps to recruit actin to endocytosis sites) and by
inhibitors of protein kinase C (PKC), Src or Rho kinase (ROCK). They have thus
identified a novel endocytic mechanism as well as several of the signalling
molecules involved.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
Related articles in JCS:
- A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1
- Silvia Muro, Rainer Wiewrodt, Anu Thomas, Lauren Koniaris, Steven M. Albelda, Vladimir R. Muzykantov, and Michael Koval
JCS 2003 116: 1599-1609.
[Abstract]
[Full Text]